Mice develop obesity and lose myocardial metabolic flexibility months after exertional heat stroke
January 16, 2025 / Heat Stroke Effects / Chronic Metabolic Disorders / Obesity / Myocardial Metabolic Flexibility / Western Diet Health Risks
A single exertional heat stroke (EHS) exposure in mice induces chronic vulnerabilities, including accelerated obesity, liver steatosis, cardiac hypertrophy, and loss of myocardial metabolic flexibility, especially when paired with a Western diet. Epigenetic mechanisms likely underlie these long-term effects.
Brain neurons that respond to sugar and fat offer new insights into obesity control
January 17, 2025 / Hippocampal Neurons / Obesity / Fat Intake Regulation / Diet Research
Researchers identified distinct hippocampal neurons responsive to sugar or fat that regulate food intake, memory, and motivation. Ablating these neurons in mice reduced high-fat and high-sugar intake, offering potential therapeutic insights for obesity control.
Calibrate Unveils Fourth Annual Results Report Showcasing Sustained Weight Loss and Metabolic Health Improvements
January 15, 2024 / Calibrate Metabolic Reset Program / Sustained Weight Loss Outcomes / GLP-1 Obesity Treatment / Metabolic Health Improvements
Calibrate’s fourth annual Results Report reveals sustained 19% weight loss at 36 months and metabolic health improvements via its Metabolic Reset program, which integrates GLP-1 medications, lifestyle interventions, and personalized coaching for over 17,000 members.
Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants
January 14, 2025 / Childhood Obesity Molecular Pathways / Prenatal Factors / Metabolic Dysfunction
A multi-omics study of European children identified key biological pathways and prenatal factors, like maternal BMI and pollutants, driving childhood obesity and metabolic dysfunction. These findings offer early prevention targets for mitigating obesity-related health risks.
One Racial Group Is Less Likely to Go Through With Bariatric Surgery
January 16, 2024 / Bariatric Surgery Racial Disparities / Obesity Treatments / Metabolic Surgery / Bariatric Surgery
A 20-year study revealed racial disparities in bariatric surgery uptake, with Black patients 44% less likely to undergo surgery despite similar discussions with clinicians. Identifying barriers and improving communication may address this inequity in obesity treatment.
Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice
January 14, 2025 / FGF23 / Obesity / Metabolic Dysfunction
Adipocyte-specific deletion of FGF23 in female mice prevents diet-induced obesity, preserves lean mass, and improves metabolic dysfunction, including dyslipidemia and hepatic steatosis. These findings suggest FGF23 as a therapeutic target for obesity management, showing sexual dimorphism.
Novo Nordisk and Valo Health expand alliance for cardiometabolic diseases
January 16, 2024 / Novo Nordisk Valo Health Partnership / AI / Cardiometabolic Drug Discovery / Obesity / Drug Development / Valo Opal Computational Platform
Novo Nordisk and Valo Health expanded their $4.6 billion alliance to develop AI-driven treatments for obesity, type 2 diabetes, and cardiovascular diseases. The collaboration uses Valo’s Opal AI platform to identify novel therapeutic targets and advance drug discovery.
Sex-specific response of intramuscular fat to diet-induced obesity in rats
January 16, 2025 / Obesity Research / Intramuscular Fat in Obesity / Myosteatosis / Metabolic Syndrome / Muscle Health
This study revealed sex-specific differences in intramuscular fat infiltration and metabolic responses to a high-fat, high-sucrose diet in rats. Female rats displayed unique susceptibility to myosteatosis, dyslipidemia, and cholesterol changes, emphasizing the importance of including females in obesity research.
Obesity Diagnosis Redefined: Impact on Treatment Ahead
January 15, 2025 / Obesity Redfined Beyond BMI / Clinical vs pre-clinical Obesity / Fat Distribution / Health Risks / Obesity
A Lancet commission redefines obesity by focusing on fat distribution and health impacts rather than BMI alone. Two categories—clinical and pre-clinical obesity—enable personalized, stigma-free care, emphasizing prevention, tailored treatment, and improved resource allocation for obesity management.
Understanding the role of metabolic syndrome in prostate cancer risk: A UK Biobank prospective cohort study
January 17, 2024 / Metabolic Syndrome / Prostate Cancer / Obesity / Hypertension / Diabetes
This UK Biobank study found no overall link between metabolic syndrome and prostate cancer risk. However, hypertension and obesity significantly increased risk, while prediabetes/diabetes and low cholesterol were protective. Targeting modifiable factors may aid prostate cancer prevention.
Exploration of the shared diagnostic genes and molecular mechanism between obesity and atherosclerosis via bioinformatic analysis
January 17, 2024 / Obesity / Atherosclerosis Link / Molecular Mechanisms of Obesity / Chronic Disease
Bioinformatic analysis identified SAMSN1 and PHGDH as shared diagnostic genes linking obesity and atherosclerosis. These genes influence immune cell infiltration and disease pathways, highlighting molecular mechanisms that may inform future diagnostic and therapeutic strategies for these comorbid conditions.
Intestinal bacterium found to reduce sugar intake in diabetic mice and humans
January 17, 2025 / Gut Microbiome / Diabetes / Metabolic Disease Therapy / Sugar Intake
Researchers identified the gut microbe Bacteroides vulgatus and its metabolite, pantothenic acid, as regulators of sugar intake via the FFAR4-GLP-1-FGF21 hormone axis. Targeting this gut-liver-brain interaction offers potential therapies for diabetes and metabolic diseases.
Separate orexigenic hippocampal ensembles shape dietary choice by enhancing contextual memory and motivation
January 15, 2025 / Hippocampus / Dietary Choices / Obesity / Obesity Treatment
Hippocampal neurons responsive to fat or sugar regulate dietary choice through memory and motivation. Activating these neurons increases food intake, while silencing prevents weight gain. This study highlights nutrient-specific neural circuits as potential obesity treatment targets.
This diet can damage your DNA and increase cancer risk
January 15, 2025 / High-fat Diet / Liver Cancer / Fatty Liver Disease / Cancer Risk / Cellular Senescence
A high-fat, high-sugar diet damages DNA in liver cells, leading to senescence and increased liver cancer risk in fatty liver disease. This study highlights the critical link between poor diet, DNA damage, and hepatocellular carcinoma progression.
Probiotic use may decrease risk factors for metabolic syndrome
January 14, 2025 / Probiotics / Metabolic Syndrome / Gut Microbiome / Cholesterol Reduction / Metabolic Health
A 12-week trial showed probiotics Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 significantly reduced metabolic syndrome risk factors, including LDL cholesterol, BMI, waist circumference, and blood pressure, while enhancing gut microbiome diversity and short-chain fatty acid production.
The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study
January 14, 2025 / Metabolic Syndrome / Liver Cancer / Central Obesity HCC Risk / Hepatocellular Carcinoma
A Mendelian randomization study confirmed that metabolic syndrome, particularly central obesity (waist circumference), significantly increases hepatocellular carcinoma (HCC) risk. These findings highlight central obesity as a key factor in the MetS-HCC link and suggest targeted prevention strategies.
Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review
January 15, 2025 / Dietary Antioxidant Index Benefits / Metabolic Health / Oxidative Stress / Chronic Disease / Obesity / Cardiometabolic Disease Prevention
This review highlights the Dietary Antioxidant Index (DAI) as a promising tool for assessing antioxidant intake and its role in reducing risks of obesity, metabolic syndrome, cardiovascular diseases, cancer, and diabetes by combating oxidative stress and inflammation.
How heart disease in women differs from men
January 16, 2024 / Heart Disease / Women’s Health / Cardiovascular Research / Gender Differences / Menopause
Women face unique biological and socioeconomic challenges in cardiovascular health, including underdiagnosis, delayed care, and differing responses to treatment. Hormonal shifts, unique risk factors (e.g., gestational diabetes), and research gaps exacerbate outcomes, highlighting the need for gender-specific care and research inclusion.
Alterations in newborn metabolite patterns with preterm birth and diabetes in pregnancy
January 17, 2024 / Preterm Birth Metabolism / Diabetes / Pregnancy / Infant Adiposity Development / Cardiometabolic Risk in Infants
Preterm birth and maternal diabetes alter newborn metabolite patterns, affecting lipid and protein metabolism. These metabolic changes are linked to adiposity development and potential cardiometabolic risks, highlighting the need for early metabolic assessments in vulnerable infant populations.